Original ResearchPioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus: Evaluation by FDG-PET/CT Imaging
Under an Elsevier user license
open archive
Key Words
computed tomography angiography
coronary artery disease
18F-fluorodeoxyglucose–positron emission tomography
high-sensitivity C-reactive protein
pioglitazone
vascular inflammation
Abbreviations and Acronyms
CT
computed tomography
DM
diabetes mellitus
FDG
18F-fluorodeoxyglucose
FPG
fasting plasma glucose
HbA1c
glycosylated hemoglobin
hsCRP
high-sensitivity C-reactive protein
IGT
impaired glucose tolerance
IQR
interquartile range
LMT
left main trunk
PET
positron emission tomography
SUV
standardized uptake value
TBR
target-to-background ratio
Cited by (0)
This study was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (to Drs. Tahara, Yamagishi, and Imaizumi). All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.